Zeskind Benjamin J.'s Insider Trades & SAST Disclosures

Zeskind Benjamin J.'s most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 688,000 Stock Option done . Disclosure was reported to the exchange on Feb. 3, 2026.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2026 688,000 688,000 - - Stock Option
Immuneering Corp (Class A)
Zeskind Benjamin J. Director, PRESIDENT AND CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.53 per share. 01 Jul 2025 7,015 2,312,852 - 3.5 24,792 Class A Common Stock
Immuneering Corp (Class A)
J. Zeskind Benjamin Director, PRESIDENT AND CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.38 per share. 01 Jul 2025 2,985 2,305,837 - 3.4 10,087 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.39 per share. 18 Jun 2025 21,000 2,302,852 - 2.4 50,144 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 480,000 480,000 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.77 per share. 19 Mar 2024 20,000 2,281,852 - 2.8 55,326 Class A Common Stock
Immuneering Corp (Class A)
Zeskind Benjamin J. Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 244,286 244,286 - - Stock Option
Immuneering Corp (Class A)
Zeskind Benjamin J. Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 16,414 16,414 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 352,244 352,244 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 21,756 374,000 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2022 2,500 203,500 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. 22 Dec 2022 2,500 2,261,852 - 3.0 7,525 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. 12 Apr 2022 2,000 2,259,352 - 3.0 6,020 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Apr 2022 2,000 206,000 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 8.02 per share. 23 Mar 2022 3,000 2,257,352 - 8.0 24,060 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2022 2,000 208,000 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. 28 Feb 2022 2,000 2,254,352 - 3.0 6,020 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 156,485 156,485 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 45,615 202,100 - - Stock Option
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, PRESIDENT AND CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 22.87 per share. 13 Sep 2021 2,083 2,602,352 - 22.9 47,632 Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, President and CEO, Ten Percent Owner 03 Aug 2021 49,099 2,598,171 - - Class A Common Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, President and CEO, Ten Percent Owner 03 Aug 2021 40,928 0 - - Series A Preferred Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, President and CEO, Ten Percent Owner 03 Aug 2021 8,171 0 - - Series B Preferred Stock
Immuneering Corp (Class A)
Benjamin J. Zeskind Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 15.00 per share. 03 Aug 2021 2,098 2,600,269 - 15 31,470 Class A Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades